61
Views
10
CrossRef citations to date
0
Altmetric
Reviews

Novel assays and novel strains – promising routes to new antibiotics?

, PhD, , PhD, , PhD, , PhD & , PhD
Pages 789-798 | Published online: 26 Jul 2007

Bibliography

  • FERNANDES P: Antibacterial discovery and development-the failure of success? Nat. Biotechnol. (2006) 24:1497-1503.
  • PAYNE DJ, GWYNN MN, HOLMES DJ, POMPLIANO DL: Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. (2007) 6:29-40.
  • NEWMAN DJ, CRAGG GM, SNADER KM: Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. (2003) 66:1022-1037.
  • BUTLER MS: Natural products to drugs: natural product derived compounds in clinical trials. Nat. Prod. Rep. (2005) 22:162-195.
  • BULL AT, WARD AC, GOODFELLOW M: Search and discovery strategies for biotechnology: the paradigm shift. Microbiol. Mol. Biol. Rev. (2000) 64:573-606.
  • WATVE MG, TICKOO R, JOG M, BHOLE BD: How many antibiotics are produced by the genus Streptomyces? Arch. Microbiol. (2001) 176:386-390.
  • HOPWOOD DA: The Streptomyces genome-be prepared! Nat. Biotechnol. (2003) 21:505-506.
  • BALTZ RH: Antibiotic discovery from actinomycetes: will a renaissance follow the decline and fall? SIM News (2005) 55:186-196.
  • RIEDLINGER J, REICKE A, ZÄHNER H et al.: Abyssomicins, inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032. J. Antibiotics (2004) 57:271-279.
  • WANG J, SOISSON SM, YOUNG K et al.: Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature (2006) 441:358-361.
  • YOUNG K, JAYASURIYA H, ONDEYKA JG et al.: Discovery of FabH/FabF inhibitors from natural products. Antimicrob. Agents Chemother. (2006) 50:519-526.
  • MDLULI KE, WITTE PR, KLINE T et al.: Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. (2006) 50:2178-2184.
  • ARHIN F, BELANGER O, CIBLAT S et al.: A new class of small molecule RNA polymerase inhibitors with activity against rifampicin-resistant Staphylococcus aureus. Bioorg. Med. Chem. (2006) 14:5812-5832.
  • DANDLIKER PJ, PRATT SD, NILIUS AM et al.: Novel antibacterial class. Antimicrob. Agents Chemother. (2003) 47:3831-3839.
  • CHOI KJ, YU YG, HAHN HG, CHOI JD, YOON MY: Characterization of acetohydroxyacid synthase from Mycobacterium tuberculosis and the identification of its new inhibitor from the screening of a chemical library. FEBS Lett. (2005) 579:4903-4910.
  • HAN C, WANG L, YU K et al.: Biochemical characterization and inhibitor discovery of shikimate dehydrogenase from Helicobacter pylori. FEBS J. (2006) 273:4682-4692.
  • POEHLSGAARD J, DOUTHWAITE S: The bacterial ribosome as a target for antibiotics. Nat. Rev. Microbiol. (2005) 3:870-881.
  • HARMS JM, BARTELS H, SCHLUNZEN F, YONATH A: Antibiotics acting on the translational machinery. J. Cell Sci. (2003) 116:1391-1393.
  • TENSON T, MANKIN A: Antibiotics and the ribosome. Mol. Microbiol. (2006) 59:1664-1677.
  • BOTTGER EC: The ribosome as a drug target. Trend Biotechnol. (2006) 24:145-147.
  • BOTTGER EC, SPRINGER B, PRAMMANANAN T, KIDAN Y, SANDER P: Structural basis for selectivity and toxicity of ribosomal antibiotics. EMBO Rep. (2001) 2:318-323.
  • SCHUWIRTH BS. BOROVINSKAYA MA, HAU CW et al.: Structures of the bacterial ribosome at 3.5 A resolution. Science (2005) 310:827-834.
  • YUSUPOV MM, YUSUPOVA GZ, BAUCOM A et al.: Crystal structure of the ribosome at 5.5 A resolution. Science (2001) 292:883-896.
  • HARMS J, SCHLUENZEN F, ZARIVACH R et al.: High resolution structure of the large ribosomal subunit from a mesophilic eubacterium. Cell (2001) 107:679-688.
  • BAN N, NISSEN P, HANSEN J, MOORE PB, STEITZ TA: The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Science (2000) 289:905-920.
  • NISSEN P, HANSEN J, BAN N, MOORE PB, STEITZ TA: The structural basis of ribosome activity in peptide bond synthesis. Science (2000) 289:920-930.
  • WIMBERLY BT, BRODERSEN DE, CLEMONS WM JR et al.: Structure of the 30S ribosomal subunit. Nature (2000) 407:327-339.
  • SCHLUENZEN F, TOCILJ A, ZARIVACH R et al.: Structure of functionally activated small ribosomal subunit at 3.3 angstroms resolution. Cell (2000) 102:615-623.
  • CALOGERO RA, PON CL, CANONACO MA, GUALERZI CO: Selection of the mRNA translation initiation region by Escherichia coli ribosomes. Proc. Natl. Acad. Sci. USA (1998) 85:6427-6431.
  • BRANDI L, FABBRETTI A, MILON P, CAROTTI M, PON CL, GUALERZI CO: Methods for identifying compounds that specifically target translation. Methods Enzymol. (2007) (in press).
  • BRANDI L, LAZZARINI A, CAVALETTI L et al.: Novel tetrapeptide inhibitors of bacterial protein synthesis produced by a Streptomyces sp. Biochemistry (2006) 45:3692-3702.
  • BRANDI L, FABBRETTI A, LA TEANA A et al.: Specific, efficient, and selective inhibition of prokaryotic translation initiation by a novel peptide antibiotic. Proc. Natl. Acad. Sci. USA (2006) 103:39-44.
  • BRANDI L, FABBRETTI A, DI STEFANO M, LAZZARINI A, ABBONDI M, GUALERZI CO: Characterization of GE82832, a peptide inhibitor of translocation interacting with bacterial 30S ribosomal subunits. RNA (2006) 12:1262-1270.
  • FRANK J, AGRAWAL RK: A ratchet-like inter-subunit reorganization of the ribosome during translocation. Nature (2000) 406:318-322.
  • MOORE BS: Biosynthesis of marine natural products: microorganisms (Part A). Nat. Prod. Rep. (2005) 22:580-593.
  • FORTMAN JL, SHERMAN DH: Utilizing the power of microbial genetics to bridge the gap between the promise and the application of marine natural products. ChemBioChem (2005) 6:960-978.
  • LAM KS: Discovery of novel metabolites from marine actinomycetes. Curr. Opin. Microbiol. (2006) 9:245-251.
  • MINCER TJ, JENSEN PR, KAUFFMAN A, FENICAL W: Widespread and persistent populations of a major new marine actinomycete taxon in ocean sediments. Appl. Environ. Microbiol. (2002) 68:5005-5011.
  • MALDONADO LA, FENICAL W, JENSEN PR et al.: Salinispora arenicola gen. nov., sp. nov. and Salinisporatropica sp. nov., obligate marine actinomycetes belonging to the family Micromonosporaceae. Int. J. Syst. Evol. Microbiol. (2005) 55:1759-1766.
  • MINCER TJ, FENICAL W, JENSEN PR: Culture-dependent and culture-independent diversity within the obligate marine actinomycete genus Salinispora. Appl. Environ. Microbiol. (2005) 71:7019-7028.
  • JENSEN PR, GONTANG E, MAFNAS C, MINCER TJ, FENICAL W: Culturable marine actinomycete diversity from tropical Pacific Ocean sediments. Environ. Microbiol. (2005) 7:1039-1048.
  • KIM TK, GARSON MJ, FUERST JA: Marine actinomycetes related to the “Salinospora” group from the Great Barrier Reef sponge Pseudoceratina clavata. Environ. Microbiol. (2005) 7:509-518.
  • JENSEN PR, MAFNAS C: Biogeography of the marine actinomycete Salinispora. Environ. Microbiol. (2006) 8:1881-1888.
  • FELING RH, BUCHANAN GO, MINCER TJ, KAUFFMAN CA, JENSEN PR, FENICAL W: Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora. Angew. Chem. Int. Ed. Engl. (2003) 42:355-357.
  • WILLIAMS PG, BUCHANAN GO, FELING RH, KAUFFMAN CA, JENSEN PR, FENICAL W: New cytotoxic salinosporamides from the marine actinomycete Salinispora tropica. J. Org. Chem. (2005) 70:6196-6203.
  • BUCHANAN GO, WILLIAMS PG, FELING RH, KAUFFMAN CA, JENSEN PR, FENICAL W: Sporolides A and B: structurally unprecedented halogenated macrolides from the marine actinomycete Salinispora tropica. Org. Lett. (2005) 7:2731-2734.
  • OH DC, WILLIAMS PG, KAUFFMAN CA, JENSEN PR, FENICAL W: Cyanosporasides A and B, chloro- and cyano-cyclopenta[a]indene glycosides from the marine actinomycete ‘Salinispora pacifica’. Org. Lett. (2006) 8:1021-1024.
  • JENSEN PR, MINCER TJ, WILLIAMS PG, FENICAL W: Marine actinomycete diversity and natural product discovery. Antonie Van Leeuwenhoek (2005) 87:43-48.
  • KIM TK, HEWAVITHARANA AK, SHAW PN, FUERST JA: Discovery of a new source of rifamycin antibiotics in marine sponge actinobacteria by phylogenetic prediction. Appl. Environ. Microbiol. (2006) 72:2118-2125.
  • MAGARVEY NA, KELLER JM, BERNAN V, DWORKIN M, SHERMAN DH: Isolation and characterization of novel marine-derived actinomycete taxa rich in bioactive metabolites. Appl. Environ. Microbiol. (2004) 70:7520-7529.
  • KWON HC, KAUFFMAN CA, JENSEN PR, FENICAL W: Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus “Marinispora”. J. Am. Chem. Soc. (2006) 128:1622-1632.
  • SORIA-MERCADO IE, PRIETO-DAVO A, JENSEN PR, FENICAL W: Antibiotic terpenoid chloro-dihydroquinones from a new marine actinomycete. J. Nat. Prod. (2005) 68:904-910.
  • FIEDLER HP, BRUNTNER C, BULL AT et al.: Marine actinomycetes as a source of novel secondary metabolites. Antonie Van Leeuwenhoek (2005) 87:37-42.
  • RHEIMS H, SCHUMANN P, ROHDE M, STACKEBRANDT E: Verrucosispora gifhornensis gen. nov., sp. nov., a new member of the actinobacterial family Micromonosporaceae. Int. J. Syst. Bacteriol. (1998) 48:1119-1127.
  • HUGENHOLTZ P: Exploring prokaryotic diversity in the genomic era. Genome Biol. (2002) 3:REVIEWS0003.
  • SAIT M, HUGENHOLTZ P, JANSSEN PH: Cultivation of globally distributed soil bacteria from phylogenetic lineages previously only detected in cultivation-independent surveys. Environ. Microbiol. (2002) 4:654-666.
  • RAPPÉ, MS, GIOVANNONI SJ: The uncultured microbial majority. Annu. Rev. Microbiol. (2003) 57:369-394.
  • HANDELSMAN J: Metagenomics: application of genomics to uncultured microorganisms. Microbiol. Mol. Biol. Rev. (2004) 68:669-685.
  • ZENGLER K, TOLEDO G, RAPPE M et al.: Cultivating the uncultured. Proc. Natl. Acad. Sci. USA. (2002) 99:15681-15686.
  • DONADIO S, BUSTI E, MONCIARDINI P et al.: Sources of polyketides and non-ribosomal peptides. In: Biocombinatorial Approaches for Drug Finding. Wohlleben W, Spellig T, Müller-Thieman B (Eds), Ernst Schering Res. Found., Springer, Berlin (2005):19-41.
  • BUSTI E, CAVALETTI L, MONCIARDINI P et al.: Catenulispora acidiphila gen. nov., sp. nov., a novel, mycelium-forming actinomycete, and proposal of Catenulisporaceae fam. nov. Int. J. Syst. Evol. Microbiol. (2006) 56:1741-1746.
  • CAVALETTI L, MONCIARDINI P, SCHUMANN P et al.: Actinospica robiniae gen. nov., sp. nov. and Actinospica acidiphila sp. nov.: proposal for Actinospicaceae fam. nov. and Catenulisporinae subord. nov. in the order Actinomycetales. Int. J. Syst. Evol. Microbiol. (2006) 56:1747-1753.
  • BUSTI E, MONCIARDINI P, CAVALETTI L et al.: Antibiotic-producing ability by representatives of a newly discovered lineage of actinomycetes. Microbiology (2006) 152:675-683.
  • JANSSEN PH, SCHUHMANN A, MÖRSCHEL E, RAINEY FA: Novel anaerobic ultramicrobacteria belonging to the Verrucomicrobiales lineage of bacterial descent isolated by dilution culture from anoxic rice paddy soil. Appl. Environ. Microbiol. (1997) 63:1382-1388.
  • TAMURA T, ZHIHENG L, YAMEI Z, HATANO K: Actinoalloteichus cyanogriseus gen. nov., sp. nov. Int. J. Syst. Evol. Microbiol. (2000) 50:1435-1440.
  • TAMURA T, HATANO K, SUZUKI K: A new genus of the family Micromonosporaceae, Polymorphospora gen. nov., with description of Polymorphospora rubra sp. nov. Int. J. Syst. Evol. Microbiol. (2006) 56:1959-1964.
  • CAVALETTI L, MONCIARDINI P, BAMONTE R et al.: New lineage of filamentous, spore-forming, gram-positive bacteria from soil. Appl. Environ. Microbiol. (2006) 72:4360-4369.
  • JOSEPH SJ, HUGENHOLTZ P, SANGWAN P, OSBORNE CA, JANSSEN PH: Laboratory cultivation of widespread and previously uncultured soil bacteria. Appl. Environ. Microbiol. (2003) 69:7210-7215.
  • CURTIS TP, SLOAN WT, SCANNELL JW: Estimating prokaryotic diversity and its limits. Proc. Natl. Acad. Sci. USA. (2002) 99:10494-10499.
  • DANIEL R: The soil metagenome-a rich resource for the discovery of novel natural products. Curr. Opin. Biotechnol. (2004) 15:199-204.
  • LAUTRU S, DEETH RJ, BAILEY LM, CHALLIS GL: Discovery of a new peptide natural product by Streptomyces coelicolor genome mining. Nat. Chem. Biol. (2005) 1:265-269.
  • GROSS H, STOCKWELL VO, HENKELS MD, NOWAK-THOMPSON B, LOPER JE, GERWICK WH: The genomisotopic approach: a systematic method to isolate products of orphan biosynthetic gene clusters. Chem. Biol. (2007) 14:53-63.
  • ZAZOPOULOS E, HUANG K, STAFFA A et al.: A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat. Biotechnol. (2003) 21:187-190.
  • MCALPINE JB, BACHMANN BO, PIRAEE M et al.: Microbial genomics as a guide to drug discovery and structural elucidation: ECO-02301, a novel antifungal agent, as an example. J. Nat. Prod. (2005) 68:493-496.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.